Controlled TGF-β3 release from porous poly(ε-caprolactone) carriers

Z. G. Tang*, R. A. Black, J. M. Curran, D. F. Williams, A. D. Metcalfe, M. W.J. Ferguson

*Corresponding author for this work

Research output: Chapter in Book/Report/Conference proceedingConference contribution


The fabrication and characterization of porous scaffolds for use in drug delivery which release effective amounts of TGF-β3 was studied. The density of both PCL and NaCl were determined by densitometry using micromeritics Accupyc 1330. The study suggests that a porous PCL carrier was made from salt leaching of NaCl particles. This carrier was able to control release of TGF-β3 in 4 days and continue the release of TGF-β3 very slowly up to 11 days.

Original languageEnglish
Title of host publicationTransactions - 7th World Biomaterials Congress
Number of pages1
Publication statusPublished - 1 Dec 2004
EventTransactions - 7th World Biomaterials Congress - Sydney, Australia
Duration: 17 May 200421 May 2004


ConferenceTransactions - 7th World Biomaterials Congress

ASJC Scopus subject areas

  • General Engineering


Dive into the research topics of 'Controlled TGF-β3 release from porous poly(ε-caprolactone) carriers'. Together they form a unique fingerprint.

Cite this